Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.
| Distributed by / for | Exelan Pharmecuticals, Inc., Boca Raton, FL 33432 |
| NDC | 76282-708-50 |
| Full product label | Difluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX only, Manufactured for Exelan Pharmecuticals, Inc., Boca Raton, FL 33432, NDC 76282-708-50. |
| Recalling firm | CIPLA |
| Distribution | Nationwide in the USA |
| Quantity | 3,468 bottles |
| Recall initiated | 2022-08-22 |
| Report date | 2022-09-14 |
| Recall completed | 2023-11-27 |
| Recall number | D-1498-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Warren NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗